Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Int J Biol Macromol ; 253(Pt 8): 127544, 2023 Dec 31.
Article in English | MEDLINE | ID: mdl-37866570

ABSTRACT

Photodynamic therapy is an alternative treatment for several pathologies, including cancer. This therapy uses a photosensitizer capable of producing reactive oxygen species through irradiation, promoting cellular death. A limitation of photosensitizers is their low solubility in aqueous media. Hence, developing a suitable carrier for photosensitizers for specific applications is a challenge. Cervical cancer is one of the most common cancers in women, and photodynamic therapy could be an attractive alternative therapeutic approach. In this work, we synthesized films composed of chitosan, polyvinylpyrrolidone, and liposomes containing Zn-phthalocyanine. Photophysical characterization of ZnPc incorporated into films was determined by UV-vis and fluorescence. Film properties such as swelling, mechanical properties, and water vapor permeability were performed. Finally, in vitro, photodynamic evaluation of these films was performed on HeLa cells. The results indicate that incorporating Zn-Pc-liposomes into films decreases cell viability by >95 %.


Subject(s)
Chitosan , Organometallic Compounds , Photochemotherapy , Female , Humans , Liposomes , Photosensitizing Agents/pharmacology , HeLa Cells , Photochemotherapy/methods , Zinc Compounds
2.
Soft Matter ; 19(43): 8378-8385, 2023 Nov 08.
Article in English | MEDLINE | ID: mdl-37873678

ABSTRACT

Magnetite (Fe3O4) nanoparticles (MNPs) as nanocatalysts have drawn considerable attention because of their unique properties such as peroxidase-like activity. However, their biodistribution and availability for specific treatments still need to be improved. In this study, a simple and convenient strategy for the synthesis of hybrid nanogels (NGs) is described, which involves direct mixing of biomaterials such as chitosan (Ch) and tannic acid (TA), with the incorporation of MNPs, under oxidising conditions, using the inverse nanoemulsion method. The different processes involved in the formation of these hybrid nanosystems as well as their morphological and chemical structure are investigated using optical, spectroscopic, and electron microscopic techniques (DLS, UV-VIS, FT-IR, XPS, TEM, and SEM-EDS). It is demonstrated that ∼11 nm synthesized MNPs, post-functionalized with oxidised TA, act as covalent crosslinkers. As a proof of concept, the potential use of these materials in nanocatalytic medicine was evaluated using a colorimetric method based on the oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) in hydrogen peroxide. The results show that these hybrid nanogels have the same peroxidase-like activity as bare MNPs, indicating that the organic nanostructure stabilises the inorganic nanoparticles without any significant change in the catalytic properties. Therefore, this kind of nanomaterial has promising potential for use in nanocatalytic medicine with improved biocompatibility and biodistribution.

3.
ACS Biomater Sci Eng ; 8(11): 5027-5037, 2022 11 14.
Article in English | MEDLINE | ID: mdl-36318285

ABSTRACT

The design of ultratough hydrogels has recently emerged as a topic of great interest in the scientific community due to their ability to mimic the features of biological tissues. An outstanding strategy for preparing these materials relies on reversible and dynamic cross-links within the hydrogel matrix. In this work, inspired by the composition of ascidians' tunic, stretchable supramolecular hydrogels combining poly(vinyl alcohol), green tea-derived gallic acid, and rigid tannic acid-coated cellulose nanocrystals (TA@CNC) were designed. The addition of TA@CNC nanofillers in concentrations up to 1.2 wt % significantly impacted the mechanical and viscoelastic properties of the hydrogels due to the promotion of hydrogen bonding with the polymer matrix and polyphenols π-π stacking interactions. These supramolecular associations endow the hydrogels with excellent stretchability and strength (>340%, 540 kPa), low thermoreversible gel-sol transition (60 °C), and remolding ability, while the natural polyphenols provided potential antibacterial properties. These versatile materials can be anticipated to open up new prospects for the rational design of polyphenol-based cellulosic hydrogels for different biomedical applications.


Subject(s)
Nanocomposites , Urochordata , Animals , Cellulose/pharmacology , Cellulose/chemistry , Nanogels , Hydrogels/pharmacology , Hydrogels/chemistry , Anti-Bacterial Agents/pharmacology
4.
Macromol Rapid Commun ; 40(18): e1900217, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31535770

ABSTRACT

Supramolecular hydrogels have promising applications in a wide variety of fields including 3D bioprinting, sensors and actuators, biomedicine, and controlled drug delivery. This communication reports the facile reversible thermotriggered formation of novel pH-responsive supramolecular hydrogels based on poly(vinyl alcohol) (PVA) bonded via dynamic H-bridge with small phenolic biomolecules. PVA and phenolic compounds form a clear solution when they are physically mixed in water at high temperature, but a fast gelation is produced at room temperature through multiple strong H-bonding interactions. The structure and type of functional groups of different phenolic molecules allow preparing hydrogels with tailor-made viscoelastic properties, controlled low phase transition temperature, and pH-dependent swelling behavior. This combination makes these supramolecular networks very interesting candidates to be used in 3D bioprinting and topical drug delivery of thermolabile biomolecules.


Subject(s)
Hydrogels/chemistry , Phenols/chemistry , Polyvinyl Alcohol/chemistry , Drug Delivery Systems/methods , Hydrogels/chemical synthesis , Hydrogen Bonding , Phase Transition , Temperature , Viscoelastic Substances/chemistry
5.
Sci Rep ; 9(1): 5732, 2019 04 05.
Article in English | MEDLINE | ID: mdl-30952921

ABSTRACT

Stimuli-responsive nanogels offer promising perspectives for the development of next generation formulations for biomedical applications. In this work, poly(N-vinylcaprolactam) nanogels were synthesized varying the concentration of monomer and crosslinking agent. Thus, the inhibitory effect of poly(N-vinylcaprolactam) nanogels against HIV-1 infection is presented for the first time. In particular, we have demonstrated that one of the synthesized poly(N-vinylcaprolactam) nanogels with initial concentration of 80 mg of vinylcaprolactam and 4% of crosslinking agent shows antiviral behavior against HIV-1 infection since this nanogel inhibits the viral replication in TZM.bl target cells.


Subject(s)
Antiviral Agents/pharmacology , Caprolactam/analogs & derivatives , Cell Survival/drug effects , HIV-1/drug effects , Nanogels/administration & dosage , Polymers/pharmacology , Virus Replication/drug effects , Caprolactam/pharmacology
6.
Eur J Pharm Biopharm ; 130: 115-122, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29932977

ABSTRACT

The use of thermoresponsive nanogels (NGs) allows the controlled release of therapeutic molecules upon a thermal switch. Usually, this strategy involves the use of temperature increase to activate cargo expulsion from shrinking NGs. In this study, poly(N-isopropylacrylamide) (pNIPAM)-based NGs were involved in the release of a therapeutic protein corona by temperature decrease. NGs based on dendritic polyglycerol (dPG) and thermoresponsive pNIPAM were semi-interpenetrated with poly(4-acryloylamine-4-(carboxyethyl)heptanodioic acid) (pABC). The resulting semi-interpenetrated NGs retain the thermoresponsive properties of pNIPAM, together with pH-responsive, dendritic pABC as a secondary network, in one single nanoparticle. Semi-interpenetrated polymer network (SIPN) NGs are stable in physiological conditions, exhibit a reversible phase transition at 35 °C, together with tunable electrophoretic mobilities around the body temperature. The binding of cytochrome c (cyt c) was successful on SIPN NGs in their collapsed state at 37 °C. Upon cooling of the samples to room temperature, the swelling of the NG effectively boosted the release of cyt c, as compared with the same kept at constant 37 °C. These responsive SIPN NGs were able to deliver cyt c to cancer cells and specifically induce apoptosis at 30 °C, while the cells remained largely unaffected at 37 °C. In this way, we show therapeutic efficacy of thermoresponsive NGs as protein carriers and their efficacy triggered by temperature decrease. We envision the use of such thermal trigger as relevant for the treatment of superficial tumors, in which induction of apoptosis can be controlled by the application of local cooling agents.


Subject(s)
Apoptosis/drug effects , Cytochromes c/administration & dosage , Nanoparticles , Polymers/chemistry , Acrylic Resins/chemistry , Chemistry, Pharmaceutical/methods , Cytochromes c/pharmacology , Delayed-Action Preparations , Dendrimers/chemistry , Drug Carriers/chemistry , Gels , Glycerol/chemistry , HeLa Cells , Heptanoic Acids/chemistry , Humans , Hydrogen-Ion Concentration , Phase Transition , Temperature
7.
Eur J Pharm Sci ; 120: 107-122, 2018 Jul 30.
Article in English | MEDLINE | ID: mdl-29705213

ABSTRACT

Interpolyelectrolyte complexes (IPEC) formulated as multiparticulate drug delivery systems (MDDS) are interesting carriers to improve drug' performance. Benznidazole (BZ) is the first-line drug for Chagas treatment; however, it presents side effects and toxicity, conditioning its efficacy and safety. The goal of this work was to obtain novel MDDS composed by IPEC based on different polymethacrylate carriers loaded with BZ and to investigate in vitro drug delivery performance for oral administration. Physicochemical characterizations were studied and preclinical studies in a murine model of acute Chagas disease were also performed. The MDDS composed by BZ-loaded IPEC based on polymethacrylates were obtained by casting solvent followed by wet granulation methods with yields >83%. FT-IR demonstrated ionic interaction between the polyelectrolytes. Confocal microscopy, DSC and PXRD revealed a fraction uniformly distributed of free BZ on the multiparticles. The rheological evaluation of the MDDS showed adequate flow features for their formulation in hard gelatin-capsules. The type and composition of IPEC conditioned the modulation of BZ release and fluid uptake results. MDDS based on more hydrophylic Eudragit® showed very fast dissolution (Q15min > 85%), while an extended release (Q120min ≤ 40%) for the hydrophobic ones was observed. Capsules containing a combination of two MDDS with different release profile of BZ showed promising properties to improve Chagas disease pharmacotherapy in the preliminary in vivo assay performed, in which the BZ-loaded MDDS exhibited efficacy to reduce parasitemia, while decreasing the levels of liver injury markers in comparison to BZ conventional treatment. Multi-kinetic BZ delivery systems developed are interesting pharmaceutical alternatives to improve the treatment of Chagas disease.


Subject(s)
Drug Carriers , Drug Delivery Systems/methods , Nitroimidazoles/administration & dosage , Polyelectrolytes/chemistry , Polymethacrylic Acids/chemistry , Trypanocidal Agents/administration & dosage , Adhesiveness , Administration, Oral , Animals , Capsules , Chagas Disease/drug therapy , Chagas Disease/parasitology , Disease Models, Animal , Drug Compounding , Drug Liberation , Gelatin/chemistry , Hydrophobic and Hydrophilic Interactions , Kinetics , Male , Mice, Inbred BALB C , Nitroimidazoles/chemistry , Particle Size , Rheology , Solubility , Spectroscopy, Fourier Transform Infrared , Technology, Pharmaceutical/methods , Trypanocidal Agents/chemistry
8.
Carbohydr Polym ; 175: 75-86, 2017 Nov 01.
Article in English | MEDLINE | ID: mdl-28917926

ABSTRACT

The bioadhesive polymeric films as topical drug delivery systems are interesting alternatives to improve the pharmacotherapy and patient compliances. New derivate biomaterials based on weisocyanate- dendronized PVP- crosslinked chitosan and loaded with ciprofloxacin (CIP), as model drug, were used to prepare bioadhesive films. Relevant in vitro/in vivo attributes to define main physicochemical and biopharmaceutical characteristics for topical wound-healing applications were evaluated. A high proportion of CIP, uniformly dispersed along throughout the film, was loaded. An extended release of CIP and different behaviors of release profiles, depending on the presence of dendron, were observed. The films loaded with CIP were effective in inhibiting the growth of both Gram positive and Gram negative bacteria. In addition, biocompatibility and bioadhesion into conjuntival-sacs of the rabbits suggests that these films have good properties to be applied over skin wounds for topical applications, allowing a reduction of the frequency of administration and improving the residence time of the films.


Subject(s)
Bandages , Biocompatible Materials , Chitosan/chemistry , Ciprofloxacin/administration & dosage , Drug Delivery Systems , Animals , Rabbits
9.
J Colloid Interface Sci ; 496: 243-253, 2017 06 15.
Article in English | MEDLINE | ID: mdl-28235718

ABSTRACT

Organic macromolecules with dendrimeric architectures are polymeric materials potentially useful as nanocarriers for therapeutic drugs. In this work, we evaluate a series of Newkome-type dendrons in Langmuir and Langmuir-Blodgett films as platforms capable of interacting with a potential antitumoral agent. The nanocomposite is proposed as model for the development of surface mediated drug delivery systems. We were successful in the formation and characterization of pure (dendrons) and composite (drug-dendron) stable and reproducible monolayers, and their transfer to solid substrates. A detailed study of topographic characteristics of the generated surfaces by atomic force microscopy was conducted. Furthermore, we probed dendron monolayer films as anchorage surfaces for mammalian cells. Normal cell attachment and proliferation on the surfaces were observed. No evident cytotoxic effects were detected, demonstrating the adequate biocompatibility of the surfaces.


Subject(s)
Dendrimers/chemistry , Drug Carriers/chemistry , Nanostructures/chemistry , Albendazole/chemistry , Albendazole/toxicity , Aniline Compounds/chemistry , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/toxicity , Biocompatible Materials/chemistry , Cell Adhesion , Cell Proliferation/drug effects , Humans , Mice , Microscopy, Atomic Force , NIH 3T3 Cells , Nitrobenzenes/chemistry , Structure-Activity Relationship , Surface Properties
10.
Molecules ; 22(2)2017 Feb 07.
Article in English | MEDLINE | ID: mdl-28178221

ABSTRACT

The immense scope of variation in dendritic molecules (hyper-branching, nano-sized, hydrophobicity/hydrophilicity, rigidity/flexibility balance, etc.) and their versatile functionalization, with the possibility of multivalent binding, permit the design of highly improved, novel materials. Dendritic-based materials are therefore viable alternatives to conventional polymers. The overall aim of this work is to show the advantages of dendronization processes by presenting the synthesis and characterization of three different dendronized systems: (I) microbeads of functionalized chitosan; (II) nanostructuration of polypropylene surfaces; and (III) smart dendritic nanogels. The particular properties yielded by these systems could only be achieved thanks to the dendronization process.


Subject(s)
Dendrimers/chemistry , Nanostructures/chemistry , Polypropylenes/chemistry , Chitosan/chemistry , Hydrophobic and Hydrophilic Interactions , Polymers , Surface Properties , Titanium/chemistry
11.
ChemMedChem ; 7(12): 2134-43, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23086693

ABSTRACT

The introduction of a methylenthiol group at position 7 of camptothecin was carried out in four steps. This preparation also yielded the corresponding disulfide, which behaves as a prodrug due to its reactivity with glutathione. Assessment of their antiproliferative activities, investigations of their mechanism of action, and molecular modeling analysis indicated that the 7-modified camptothecin derivatives described herein maintain the biological activity and drug-target interactions of the parent compound.


Subject(s)
Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Camptothecin/analogs & derivatives , Camptothecin/pharmacology , Prodrugs/chemistry , Prodrugs/pharmacology , Antineoplastic Agents, Phytogenic/chemical synthesis , Antineoplastic Agents, Phytogenic/metabolism , Camptothecin/chemical synthesis , Camptothecin/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , DNA Topoisomerases/metabolism , Glutathione/metabolism , Humans , Models, Molecular , Neoplasms/drug therapy , Neoplasms/enzymology , Prodrugs/chemical synthesis , Prodrugs/metabolism , Topoisomerase I Inhibitors/chemical synthesis , Topoisomerase I Inhibitors/chemistry , Topoisomerase I Inhibitors/metabolism , Topoisomerase I Inhibitors/pharmacology
12.
Chemistry ; 17(22): 6221-6, 2011 May 23.
Article in English | MEDLINE | ID: mdl-21506188

ABSTRACT

An efficient total synthesis of the natural alkaloid (+)-dumetorine by using flow technology is described. The process entailed five separate steps starting from the enantiopure (S)-2-(piperidin-2-yl)ethanol 4 with 29% overall yield. Most of the reactions were carried out by exploiting solvent superheating and by using packed columns of immobilized reagents or scavengers to minimize handling. New protocols for performing classical reactions under continuous flow are disclosed: the ring-closing metathesis reaction with a novel polyethylene glycol-supported Hoveyda catalyst and the unprecedented flow deprotection/Eschweiler-Clarke methylation sequence. The new protocols developed for the synthesis of (+)-dumetorine were applied to the synthesis of its simplified natural congeners (-)-sedamine and (+)-sedridine.


Subject(s)
Alkaloids/chemical synthesis , Piperidines/chemical synthesis , Solvents/chemistry , Alkaloids/chemistry , Catalysis , Cyclization , Molecular Structure , Piperidines/chemistry , Stereoisomerism , Technology , Temperature
13.
J Org Chem ; 74(9): 3540-3, 2009 May 01.
Article in English | MEDLINE | ID: mdl-19351173

ABSTRACT

A continuous flow tubing reactor can be used to readily transform methyl or ethyl carboxylic esters into the corresponding hydroxamic acids. Flow rate, reactor volume, and temperature were optimized for the preparation of a small collection of hydroxamic acids. Synthetic advantages were identified as an increased reaction rate and higher product purity. This method was also successfully applied to the multistep preparation of suberoylanilide hydroxamic acid, a potent HDAC inhibitor used in anticancer therapy.


Subject(s)
Hydroxamic Acids/chemical synthesis , Esters/chemistry , Microwaves , Vorinostat
14.
Langmuir ; 24(12): 6343-50, 2008 Jun 17.
Article in English | MEDLINE | ID: mdl-18491871

ABSTRACT

The transfer of six dendritric molecules, DMs, across the water/1,2-dichloroethane interface was investigated using cyclic voltammetry. From the variation of peak potential with pH, two different mechanisms of transfer were postulated depending on the nature of the molecules. Voltammetric parameters were employed to evaluate the hydrophilic/hydrophobic character and calculate the acid dissociation constant of these molecules. The results were explained taking into account the nature and multiplicity of functional surface groups.


Subject(s)
Dendrites/metabolism , Electrochemistry/methods , Ethylene Dichlorides/chemistry , Water/chemistry , Chemistry, Physical/methods , Hydrogen-Ion Concentration , Magnetic Resonance Spectroscopy , Models, Biological , Models, Chemical , Nanoparticles , Nanotechnology/methods , Solvents/chemistry , Spectroscopy, Fourier Transform Infrared , Surface Properties
15.
Bioorg Med Chem ; 16(6): 3224-32, 2008 Mar 15.
Article in English | MEDLINE | ID: mdl-18171618

ABSTRACT

Chemical modifications of dimiracetam, a bicyclic analogue of the nootropic drug piracetam, afforded a small set of novel derivatives that were investigated in in vivo models of neuropathic pain. Compounds 5, 7 and 8 displayed a very promising antihyperalgesic profile in rat models of neuropathic pain induced by both chronic constriction injury of the sciatic nerve and streptozotocin. The compounds completely reverted the reduction of pain threshold evaluated by the paw pressure test. Importantly these derivatives did not induce any behavioural impairment as evaluated by the rotarod test. These results suggest that compounds 5, 7 and 8 might represent novel and well-tolerated therapeutic agents for the relief of neuropathic pain.


Subject(s)
Imidazoles/chemistry , Imidazoles/pharmacology , Neuralgia/drug therapy , Pyrroles/chemistry , Pyrroles/pharmacology , Animals , Behavior, Animal/drug effects , Disease Models, Animal , Imidazoles/therapeutic use , Pain Threshold/drug effects , Pyrroles/therapeutic use , Rats , Structure-Activity Relationship
16.
Chem Commun (Camb) ; (14): 1602-3, 2004 Jul 21.
Article in English | MEDLINE | ID: mdl-15263938

ABSTRACT

A two-step route for the enantioselective construction of the tetracyclic ring system of uleine alkaloids, involving the stereoselective conjugate addition of an appropriate indole-containing nucleophile to a chiral bicyclic delta-lactam and the subsequent cyclization on the indole 3-position of the resulting 4,5-disubstituted 2-piperidone, has culminated in the formal total synthesis of several alkaloids of this group.

17.
IDrugs ; 6(8): 758-72, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12917772

ABSTRACT

This review describes the patent applications and relevant scientific literature published during 2002 in the field of novel neurokinin receptor antagonists, with an emphasis on the medicinal chemistry of recent patent publications. A brief update on the development status of compounds including: the neurokinin-1 receptor antagonists aprepitant (Merck & Co Inc), vofopitant, ezlopitant (Pfizer Inc), R-673 (F Hoffmann-La Roche Ltd); the neurokinin-2 receptor antagonists nepadutant (Menarini Ricerche SpA), saredutant (Sanofi-Synthelabo), SR-144190 (Sanofi-Synthelabo) and UK-290795 (Pfizer Inc); and the neurokinin-3 receptor antagonists osanetant (Sanofi-Synthelabo) and talnetant (GlaxoSmithKline plc) will be given. The review also reports the recent published patent literature in the area of novel therapeutic uses and novel formulations and combinations claimed for neurokinin receptor antagonists.


Subject(s)
Neurokinin-1 Receptor Antagonists , Receptors, Neurokinin-2/antagonists & inhibitors , Receptors, Neurokinin-3/antagonists & inhibitors , Animals , Chemistry, Pharmaceutical , Drug Combinations , Humans , Peptides/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...